Her2. dr
Focus sul Carcinoma della Mammella: Ruolo delle Antracicline Chieti, 11 dicembre, 2012.
What’s New in HER2: Current Issues in HER2 Positive Breast Cancer Kristine Abueg, RN, MSN, OCN®, CBCN ® Oncology Clinical Trials Kaiser Permanente, Roseville.
Targeted therapy in Early Breast Cancer Paul Ellis Guy’s Hospital, London.
Clinical Dilemma: Which Adjuvant Chemotherapy is Just Right? Dr. Maureen Trudeau Head, Division of Medical Oncology/Hematology Toronto Sunnybrook Regional.
HER2/NEU and breast cancer.
